Baricitinib: menene don, yadda za'a sha shi da kuma sakamako masu illa

Wadatacce

• Menene don
• Shin ana bada shawarar baricitinib don maganin COVID-19?
• Yadda ake dauka
• Matsalar da ka iya haifar
• Wanda bai kamata yayi amfani da shi ba

Baricitinib magani ne wanda ke rage amsawar garkuwar jiki, yana rage aikin enzymes wanda ke inganta kumburi da bayyanar lalacewar haɗin gwiwa a cikin maganganun cututtukan zuciya na rheumatoid. Ta wannan hanyar, wannan magani yana iya rage kumburi, yana sauƙaƙe alamomin cutar kamar ciwo da kumburin mahaɗan.

Anvisa ya ba da wannan maganin don amfani a cikin cututtukan rheumatoid, tare da sunan kasuwanci Olumiant kuma ana iya siyan shi a shagunan sayar da magani kawai tare da takardar sayan magani, a cikin nau'i na 2 ko 4 mg Allunan.

Menene don

Ana nuna Baricitinib don rage zafi, tauri da kumburi na cututtukan zuciya na rheumatoid, ban da rage ci gaban kashi da haɗin gwiwa.

Ana iya amfani da wannan magani shi kaɗai ko a hade tare da methotrexate, a cikin maganin cututtukan zuciya na rheumatoid.

Shin ana bada shawarar baricitinib don maganin COVID-19?

An ba da izinin Baricitinib ne kawai a cikin Amurka don magance kamuwa da cuta tare da sabon abin da ake zargi da cutar coronavirus ko kuma an tabbatar da shi ta hanyar gwaje-gwajen gwaje-gwaje, lokacin da aka yi amfani da shi tare da remdesivir, wanda yake maganin ƙwayar cuta ne. Anvisa ya ba da izinin Remdesivir don nazarin gwaji don Covid-19.

Wasu nazarin sun nuna cewa wannan magani na iya taimakawa wajen toshe shigar kwayar kwayar cutar cikin kwayoyin halitta da rage lokacin dawowa da mace-mace a cikin matsakaici zuwa mawuyacin hali, ga manya da kananan yara masu asibiti sama da shekaru biyu da suke bukatar iskar oxygen, inji mai sanya iska ko kuma iskar shaka ta hanyar membrane mai karin jini. Duba duk yarda da karatun kwayoyi don Covid-19.

A cewar Anvisa, sayan baricitinib a shagunan har yanzu ana ba da izinin, amma ga mutanen da ke da takardar likita don maganin cututtukan rheumatoid.

Yadda ake dauka

Baricitinib ya kamata a sha da baki kamar yadda likitan ya shawarta, sau daya a rana, kafin ko bayan ciyarwa.

Dole ne a sha kwamfutar hannu koyaushe a lokaci guda, amma idan akwai mantuwa, ya kamata a sha maganin da zaran kun tuna sannan kuma a sake tsara jadawalin bisa ga wannan kashi na ƙarshe, a ci gaba da jinyar bisa ga sabon lokacin da aka tsara. Kar a ninka kashi biyu domin cike gurbin da aka manta.

Kafin fara magani tare da baricitinib, likitan yakamata ya bada shawarar cewa ayi gwaji don tabbatar da cewa baka da tarin fuka ko wasu cutuka.

Matsalar da ka iya haifar

Wasu daga cikin cututtukan da zasu iya faruwa yayin magani tare da baricitinib sune rashin lafiyan abubuwanda ke cikin kwayar, tashin zuciya ko haɗarin kamuwa da cututtukan da suka haɗa da tarin fuka, fungal, kwayan cuta ko ƙwayoyin cuta irin su herpes simplex ko herpes zoster.

Bugu da kari, baricitinib na iya kara kasadar kamuwa da cutar lymphoma, zurfin jijiyoyin jini ko huhu na huhu.

Ana ba da shawarar dakatar da amfani da neman taimakon likita kai tsaye idan alamun rashin lafiyar mai tsanani ga baricitinib suka bayyana, kamar wahalar numfashi, jin ƙuntatawa a cikin maƙogwaro, kumburi a baki, harshe ko fuska, ko amya, ko kuma idan kun sha baricitinib a cikin allurai waɗanda suka fi waɗanda aka ba da shawarar don bibiyar alamu da alamomin sakamako masu illa.

Wanda bai kamata yayi amfani da shi ba

Bai kamata mata masu ciki ko masu shayarwa suyi amfani da Baricitinib ba, a cikin yanayin tarin fuka ko cututtukan fungal kamar candidiasis ko pneumocystosis.

Ya kamata a yi amfani da wannan maganin tare da taka tsantsan a cikin mutanen da ke da matsalar daskarewar jini, ciki har da tsofaffi, mutane masu kiba, mutanen da ke da tarihin thrombosis ko embolism ko kuma mutanen da za su yi wani nau'in tiyata kuma suna buƙatar ta da motsi. Bugu da kari, ya kamata a yi taka-tsantsan dangane da mutanen da ke da larurar hanta ko aikin koda, karancin jini ko kuma ga mutanen da ke da karfin garkuwar jiki, wadanda na iya bukatar daidaiton magani daga likita.